MACBEATH GAVIN enters TSCAN THERAPEUTICS, INC. with 44.77K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/15/2021ACC: 0000899243-21-028516
Officer· Chief Scientific Officer
Since Jul 2021
44.77K
Baseline shares
100% direct
44.77K
Direct ownership
1 position
254.45K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Voting Common Stock
DirectShares owned44.77K
Total
44.77K direct44.77K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Voting Common Stock | 44.77K | Direct |
| Total | 44.77K | 44.77K direct |
Derivative Holdings3
Employee Stock Option (right to buy)
DirectUnderlying security
Voting Common Stock
Underlying shares
52.58K
Shares owned
N/A
Exercise price
2.46
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Voting Common Stock
Underlying shares
166.58K
Shares owned
N/A
Exercise price
5.82
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Voting Common Stock
Underlying shares
35.30K
Shares owned
N/A
Exercise price
1.97
Expiration
—
Exercise window
—
Total
Underlying
254.45K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Voting Common Stock | 2.46 | — | — | 52.58K | N/A |
| Employee Stock Option (right to buy) Direct | Voting Common Stock | 5.82 | — | — | 166.58K | N/A |
| Employee Stock Option (right to buy) Direct | Voting Common Stock | 1.97 | — | — | 35.30K | N/A |
| Total | 254.45K | 0.00 | ||||